Popular Articles

India To Provide Incentives For Medical Professionals To Work In Rural, Underserved Areas
In an effort to encourage medical professionals to provide services to low-income rural populations in India, Union Health and Family Welfare Minister Ghulam Nabi Azad announced an initiative that will significantly raise the salary of "doctors, specialists and para-medical staff" who elect to work in "rural, particularly far-flung and inaccessible areas," the Hindu reports.
generic viagra online
Eiger BioPharmaceuticals Acquires Exclusive License To Novel Hepatitis C Virus (HCV) Technology From Stanford University
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that it has licensed the exclusive worldwide rights to novel Hepatitis C Virus (HCV) technology from Stanford University. This technology, discovered in the lab of Stanford scientist and Eiger founder Dr. Jeffrey Glenn, M.D., Ph.D., is focused on a variety of novel targets, including key features of NS4B, a non-structural protein in the HCV genome, which binds to HCV-RNA and is required for viral replication.
News of the day
The Springer Dog Exerciser Helps You And Your Dog Stay Fit
If you want a safe way to take your dog with you on bike rides, the Springer dog exerciser might be the perfect answer.
Oncology

SCRIP's 'Best-In-Class' Reporting Recognised By Industry - Journalist Malani Guha Wins Advances In Renal Cancer Journalists' Award

Journalist, Malini Guha, has won the prestigious new Advances in Renal Cancer Journalists" Award - Europe for her article "New Advances Deliver Fresh Hope in Kidney Cancer" - which was published in Scrip World Pharmaceutical News on February 13th 2009. The award was presented by the esteemed Association of German Medical Journalists (VDMJ) at this month"s Fourth European International Kidney Cancer Symposium in Berlin. In her article, Malini Guha - Science Editor at Scrip - provides a concise and informative review of the current options and prospects of success in the treatment of renal cell carcinoma. "It is a great honour to be the first-ever recipient of this award," says Malini. "My article focused on the significant progress made in the treatment of kidney cancer in recent years and also examined the outlook for other approaches which may further improve patient outcomes." The jury - comprising Professor Peter Mulders, Department of Urology, University Medical Center St Radboud, Nijmwegan in the Netherlands; Dr Bernard Escudier, Institut Gustave Roussy, Villejuif in France; and Torsten Hoffman, President of the VdMJ, Stuttgart in Germany - evaluated submissions from print media and were highly complimentary of Malini"s work. The panel said: "The article comes across as both scientifically accurate and clearly comprehensible, aiming to give interested readers the necessary information on the latest research into treatment in this indication in a manner that is comprehensive and yet not overtaxing. "Guha"s writing adheres to the guiding principle of medical journalism: "do not stir up anxiety and do not raise unreasonable hopes." The article is a testament to the detailed investigative work conducted by Malini Guha herself at research centers, hospitals and amongst specialist oncologists. This, too, is a mark of good journalistic practice. Furthermore, the journalist"s own personal interest in the subject matter also contributes to the success of this commendable publication." "We are delighted that Malini"s work has been recognised so publicly in the form of this highly prestigious award," says Phil Jarvis, Publisher of Scrip World Pharmaceutical News. "It is a testament to her talent, hard work and vast knowledge of the subject matter and we are extremely proud to have published her work in Scrip." The Advances in Renal Cancer Journalists" Award - Europe was sponsored by Bayer Healthcare AG and was presented to Malini Guha on May 8th, 2009. Scrip World Pharmaceutical News


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):